share_log
Reuters ·  2024/12/31 22:24

Scisparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for Its Clinical Trial in Children With Autism Spectrum Disorder

Scisparc宣布以色列医疗大麻机构续期其针对自闭症谱系障碍儿童的临床试验批准

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发